Table 1.
Baseline characteristics in patients of the French COVID cohort who fully completed the 7-symptoms questionnaire 6 months after diagnostic confirmation.
| Category | n/ntot (%) N = 324 |
|---|---|
| Male Sex | 205/324 (63) |
| Ethnic group | |
| White | 212/264 (80) |
| Black | 25/264 (10) |
| Arab | 19/264 (7) |
| Asian | 4/264 (2) |
| Other | 4/264 (2) |
| Age | |
| Adult (18-64) | 200/324 (62) |
| Elders (>64) | 124/324 (38) |
| Smoking history | |
| Current smoker | 19/265 (7) |
| Never smoked | 171/265 (64) |
| Former smoker | 75/265 (28) |
| Health worker | 31/306 (10) |
| Intensive care unit | |
| At any time | 54/286 (19) |
| At admission | 33/302 (11) |
| Comorbidities | |
| Diabetes | 48/311 (15) |
| Hypertension | 110/311 (35) |
| Obesity | 53/304 (17) |
| Chronic cardiac disease | 57/311 (18) |
| Chronic pulmonary disease | 56/311 (18) |
| Chronic kidney disease | 16/311 (5) |
| Moderate or severe chronic liver disease | 3/311 (1) |
| Mild chronic liver disease | 4/311 (1) |
| Chronic neurological disorder | 20/311 (6) |
| Malignant neoplasm | 20/310 (6) |
| Chronic haematologic disease | 16/311 (5) |
| AIDS/HIV | 1/311 (0.3) |
| Dementia | 1/311 (0.3) |
| Rheumatologic disorder | 16/311 (5) |
| Number of comorbidities* | |
| 0 | 99/311 (32) |
| 1 | 94/311 (30) |
| 2 or more | 118/311 (38) |
* Comorbidities were defined using the Charlson comorbidity index, with the addition of clinician-defined obesity.